Origin Materials Inc. (ORGN) Insider Trading
Insiders sold $136k and bought nothing on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. The last open-market buy by an executive or director was in Nov 2024.
Get an email when ORGN's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Jan 16 | Matthew T Plavan CFO and COO | SoldNo plan | 12,000 | $0.20 | $2k | 0.9% | Form 4 |
| Dec 29, 2025 | John Bissell CEO and Director | SoldNo plan | 50,000 | $0.20 | $10k | 2.5% | Form 4 |
| Dec 24, 2025 – Dec 29, 2025 | Joshua C. Lee General Counsel | SoldNo plan 2 parts | 64,000 | $0.21 average | $14k | 9.5% | Form 4 |
| Dec 26, 2025 | Matthew T Plavan CFO and COO | SoldNo plan | 40,000 | $0.21 | $8k | 2.9% | Form 4 |
| Dec 19, 2025 | John Bissell CEO and Director | SoldNo plan | 45,000 | $0.27 | $12k | 2.2% | Form 4 |
| Dec 16, 2025 | Joshua C. Lee General Counsel | SoldNo plan | 18,200 | $0.36 | $7k | 2.6% | Form 4 |
| Nov 3, 2025 | Matthew T Plavan CFO and COO | SoldNo plan | 150,000 | $0.55 | $83k | 9.9% | Form 4 |
| Aug 21, 2025 | Joshua C. Lee General Counsel | SoldNo plan | 3,860 | $0.56 | $2k | 0.6% | Form 4 |
| Mar 5, 2025 | John Bissell CEO and Director | SoldNo plan | 20,828 | $0.85 | $18k | 1.0% | Form 4 |
| Mar 5, 2025 | Matthew T Plavan CFO and COO | SoldNo plan | 9,725 | $0.86 | $8k | 0.6% | Form 4 |
| Mar 5, 2025 | Joshua C. Lee General Counsel | SoldNo plan | 10,441 | $0.85 | $9k | 1.5% | Form 4 |
| Jan 2, 2025 | Joshua C. Lee General Counsel | Sold10b5-1 plan | 1,400 | $1.20 | $2k | 0.2% | Form 4 |
| Dec 27, 2024 | Matthew T Plavan CFO and COO | Sold10b5-1 plan | 24,500 | $1.02 | $25k | 1.7% | Form 4 |
| Dec 27, 2024 | Joshua C. Lee General Counsel | Sold10b5-1 plan | 25,000 | $1.02 | $26k | 3.8% | Form 4 |
| Dec 27, 2024 | John Bissell CEO and Director | SoldNo plan | 55,000 | $1.00 | $55k | 2.7% | Form 4 |
| Dec 13, 2024 | John Bissell Co-CEO and Director | SoldNo plan | 36,000 | $1.14 | $41k | 2.2% | Form 4 |
| Dec 13, 2024 | Joshua C. Lee General Counsel | Sold10b5-1 plan 2 parts | 47,625 | $1.08 average | $51k | 10.0% | Form 4 |
| Nov 20, 2024 | Richard J. Riley CO-CEO AND DIRECTOR | Bought | 300,000 | $1.00 | $300k | 17% | Form 4 |
| Nov 14, 2024 | Joshua C. Lee General Counsel | SoldNo plan | 8,784 | $1.24 | $11k | 1.8% | Form 4 |
| Nov 14, 2024 | John Bissell Co-CEO and Director | SoldNo plan | 6,598 | $1.25 | $8k | 0.4% | Form 4 |
| Nov 4, 2024 | Matthew T Plavan Chief Financial Officer | SoldNo plan | 120,000 | $1.32 | $158k | 8.9% | Form 4 |
- Jan 16No planMatthew T PlavanCFO and COO · sold 12,000 at $0.20$2k0.9% of stake
- Dec 29, 2025No planJohn BissellCEO and Director · sold 50,000 at $0.20$10k2.5% of stake
- Dec 24, 2025 – Dec 29, 2025No planJoshua C. LeeGeneral Counsel · sold 64,000 at avg $0.21$14k9.5% of stake
- Dec 26, 2025No planMatthew T PlavanCFO and COO · sold 40,000 at $0.21$8k2.9% of stake
- Dec 19, 2025No planJohn BissellCEO and Director · sold 45,000 at $0.27$12k2.2% of stake
- Dec 16, 2025No planJoshua C. LeeGeneral Counsel · sold 18,200 at $0.36$7k2.6% of stake
- Nov 3, 2025No planMatthew T PlavanCFO and COO · sold 150,000 at $0.55$83k9.9% of stake
- Aug 21, 2025No planJoshua C. LeeGeneral Counsel · sold 3,860 at $0.56$2k0.6% of stake
- Mar 5, 2025No planJohn BissellCEO and Director · sold 20,828 at $0.85$18k1.0% of stake
- Mar 5, 2025No planMatthew T PlavanCFO and COO · sold 9,725 at $0.86$8k0.6% of stake
- Mar 5, 2025No planJoshua C. LeeGeneral Counsel · sold 10,441 at $0.85$9k1.5% of stake
- Jan 2, 202510b5-1 planJoshua C. LeeGeneral Counsel · sold 1,400 at $1.20$2k0.2% of stake
- Dec 27, 202410b5-1 planMatthew T PlavanCFO and COO · sold 24,500 at $1.02$25k1.7% of stake
- Dec 27, 202410b5-1 planJoshua C. LeeGeneral Counsel · sold 25,000 at $1.02$26k3.8% of stake
- Dec 27, 2024No planJohn BissellCEO and Director · sold 55,000 at $1.00$55k2.7% of stake
- Dec 13, 2024No planJohn BissellCo-CEO and Director · sold 36,000 at $1.14$41k2.2% of stake
- Dec 13, 202410b5-1 planJoshua C. LeeGeneral Counsel · sold 47,625 at avg $1.08$51k10.0% of stake
- Nov 20, 2024Richard J. RileyCO-CEO AND DIRECTOR · bought 300,000 at $1.00$300k17% of stake
- Nov 14, 2024No planJoshua C. LeeGeneral Counsel · sold 8,784 at $1.24$11k1.8% of stake
- Nov 14, 2024No planJohn BissellCo-CEO and Director · sold 6,598 at $1.25$8k0.4% of stake
- Nov 4, 2024No planMatthew T PlavanChief Financial Officer · sold 120,000 at $1.32$158k8.9% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Related stocks: Industrial Organic Chemicals
Spot a number that looks wrong? Check it in ORGN's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ORGN
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.